Back to Search
MARK ABELSON, M.D.
M.D.
Ophthalmology Physician
NPI: 1811990682Individual
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
37429(MA)
Research & Publications (20)
Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
PMID 18374301·Am J Ophthalmol·2008
4-observational
A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis.
PMID 19668507·Clin Ophthalmol·2007
8-other
Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis.
PMID 14996516·Clin Ther·2004
3-trial
Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
PMID 15701212·Curr Med Res Opin·2004
3-trial
Conjunctival allergen challenge: models in the investigation of ocular allergy.
PMID 12791217·Curr Allergy Asthma Rep·2003
6-review
Alternative reference values for tear film break up time in normal and dry eye populations.
PMID 12614039·Adv Exp Med Biol·2002
8-other
Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing.
PMID 18433347·Expert Opin Drug Metab Toxicol·2008
6-review
Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge.
PMID 18085465·Curr Eye Res·2007
4-observational
Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis.
PMID 15969867·Curr Med Res Opin·2005
3-trial
Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.
PMID 15610370·Pediatr Allergy Immunol·2004
3-trial
A review of olopatadine for the treatment of ocular allergy.
PMID 15330735·Expert Opin Pharmacother·2004
6-review
Ocular allergic disease: mechanisms, disease sub-types, treatment.
PMID 17075644·Ocul Surf·2003
8-other
One-visit, randomized, placebo-controlled, conjunctival allergen challenge study of scanning and imaging technology for objective quantification of eyelid swelling in the allergic reaction with contralateral use of olopatadine and artificial tears.
PMID 12946551·Clin Ther·2003
3-trial
Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model.
PMID 12742839·Arch Ophthalmol·2003
3-trial
Dry eye syndromes: diagnosis, clinical trials and pharmaceutical treatment--'improving clinical trials'.
PMID 12614034·Adv Exp Med Biol·2002
8-other
Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.
PMID 12419098·J Ocul Pharmacol Ther·2002
3-trial
A randomized, double-blind, placebo-controlled comparison of emedastine 0.05% ophthalmic solution with loratadine 10 mg and their combination in the human conjunctival allergen challenge model.
PMID 11952027·Clin Ther·2002
3-trial
Evidence from gabbro of the Troodos ophiolite for lateral magma transport along a slow-spreading mid-ocean ridge.
PMID 11343114·Nature·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 138 HAVERHILL ST, SUITE 104
ANDOVER, MA 01810 - Phone
- (978) 475-0705
Quick Facts
- NPI
- 1811990682
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile